EIR Ventures
  • This is Eir Ventures
  • Team
  • Investments
  • Sustainability
  • News
  • Contact
    • Investor Login
    • Download
Select Page
Interview with Eir Ventures’ Stephan Christgau in NASDAQ newsletter

Interview with Eir Ventures’ Stephan Christgau in NASDAQ newsletter

by Thomas Rønn | Jan 23, 2021 | Articles

Q: Eir Ventures has now been in operations for 6 months since the launch last summer, how has that been? We were delighted to be able to reach the first close of Eir Ventures last summer. Obviously raising a new first time life science venture fund is never easy, and...
New Nordic Life Science Venture Fund, Eir Ventures, launched to leverage the untapped potential of Health Care Innovation

New Nordic Life Science Venture Fund, Eir Ventures, launched to leverage the untapped potential of Health Care Innovation

by Thomas Rønn | Jan 23, 2021 | Articles, Other News

Life sciences focused fund also announces first close of EUR76 million July 10, 2020, Stockholm & Copenhagen: Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new fund of EUR76 million. With a strong base in the Nordic region...

Recent Posts

  • Eir Ventures invests in Henlez
  • Eir Ventures portfolio company, Pretzel Therapeutics, announces USD 72,5M series A financing
  • Eir Ventures invests in Hoba Therapeutics
  • Eir Ventures joins oversubscribed investment round in Attgeno
  • Eir Ventures strengthens team – appoints three new Partners

Recent Comments

    Get in Touch
    Eir Ventures is located in Stockholm, Sweden, and Copenhagen, Denmark.
    Sweden Office
    Grev Turegatan 27
    SE-114 38 Stockholm
    Sweden
    Denmark Office
    Havnegade 39
    DK-1058 Copenhagen
    Denmark
    Contact us
    info@eirventures.eu
    ©2021 Eir Ventures.